First Quantum Minerals Announces Voting Results for the Election of Directors GlobeNewswire May 08, 2025 TORONTO, May 08, 2025 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) announced that the nominees listed in the Management Information Circular for the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) were elected […]

Colliers adds top-tier firm to Canadian engineering platform Acquisition enhances Englobe's scale and capabilities GlobeNewswire May 08, 2025 TORONTO and CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) — Colliers (NASDAQ, TSX: CIGI) announced today that its Canadian engineering platform Englobe Corporation (“Englobe”) has acquired Higher Ground Consulting Inc. (“Higher Ground”), a leading engineering consulting firm

Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire May 08, 2025 Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in

Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today GlobeNewswire May 08, 2025 WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) — Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern

Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress GlobeNewswire May 08, 2025 Topline data from multiple Phase 2 studies expected throughout 2025 • Q2 readout from VTX3232 study in patients with early Parkinson's disease • H2 readout from VTX2735 study in patients with recurrent pericarditis • H2 readout from VTX3232

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress GlobeNewswire May 08, 2025 – Generated Q1'25 Quarterly Net Revenue of $177.8 Million, Up 23% Year-over-Year – – Grew Jornay PM(R) Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million; Jornay PM Prescribers Reached an All-Time-High – – Completed Jornay

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire May 08, 2025 Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) Full results from

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial GlobeNewswire May 08, 2025 GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis GlobeNewswire May 08, 2025 Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the

(NASDAQ:DLHC), ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security, today announced that it has been awarded a five year task order valued at up to $37.7 million to continue